Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European Market
November 18 2009 - 4:45PM
PR Newswire (US)
HAYWARD, Calif., Nov. 18 /PRNewswire-FirstCall/ -- Solta Medical,
Inc. (NASDAQ:SLTM), the pioneer in fractional resurfacing and
market leader of aesthetic skin treatments, today announced its
European launch of the Fraxel re:store Dual laser system with the
recent CE Mark (Conformite Europeene) approval. The Fraxel re:store
Dual system takes the industry leading fractional laser technology
to the next level by adding a novel 1927 nm wavelength, the first
ever application of a Thulium laser in the aesthetics market. The
new Fraxel re:store Dual system is optimized for both facial
procedures and large body areas to address clearance of
pigmentation and other skin conditions all in a single treatment.
The system is now available to physicians in the European Union, as
well as many other countries around the world. This CE Mark joins
the registration obtained in September for Solta Medical's Thermage
CPT, the most advanced non-invasive skin tightening and contouring
procedure. Prior to the non-ablative Fraxel re:store Dual system,
laser skin resurfacing procedures were largely limited to the face.
The expanded versatility of the Fraxel re:store Dual system, with
the addition of the new 1927 nm wavelength, increases the areas of
the body that physicians can treat and further demonstrates Solta
Medical's dedication to producing the safest and most effective
aesthetic energy devices in the industry. "Solta Medical is
committed to developing innovative, safe, and effective anti-aging
solutions that deliver superior results for patients looking to
treat multiple body areas in one treatment session," said Stephen
J. Fanning, Chairman of the Board, President and CEO of Solta
Medical, Inc. "With the recent domestic and global registrations
for our Fraxel re:store Dual and Thermage CPT systems, we have made
significant advancements in how physicians address aging skin -
with enhanced efficacy and patient comfort in non-invasive
aesthetic treatments. The new Fraxel re:store Dual system provides
significant enhancements that enable physicians to better address
pigmentation and other dyschromia on the entire body. Fraxel
re:store Dual system features and benefits include: -- Dual fiber
laser technology in one system providing the most effective
non-ablative skin resurfacing treatment -- Accelerated clearance of
unwanted pigmentation via ground-breaking technology -- Ease of
operation and improved patient comfort with focal cooling built
directly into the hand piece -- Treatment of larger and multiple
body areas in a single session with the addition of the 1927 nm
wavelength -- Increased procedure speed by 25% with newly improved
scanner design ABOUT SOLTA MEDICAL, INC. Solta Medical is a global
leader in the medical aesthetics market providing innovative, safe,
and effective anti-aging solutions for patients that enhance and
expand the practice of medical aesthetics for physicians. The
company offers products to address aging skin under the industry's
two premier brands: Thermage® and Fraxel®. Thermage is an
innovative, non- invasive radiofrequency procedure for tightening
and contouring skin. As the leader in fractional laser technology,
Fraxel delivers minimally invasive clinical solutions to resurface
aging and sun damaged skin. Since 2002, approximately one million
Thermage and Fraxel procedures have been performed in nearly 80
countries. Thermage and Fraxel are the perfect complement for any
aesthetic practice. For more information about Solta Medical, call
1-877-782-2286 or log on to http://www.solta.com/. The Fraxel
re:store 1550 nm laser is FDA cleared for skin resurfacing and for
the treatment of pigmented lesions, acne scars, melasma, mild to
moderate periorbital rhytids, surgical scars and actinic keratosis.
The Fraxel re:store 1927 nm laser is FDA cleared for dermatological
procedures requiring the coagulation of soft tissue. © 2009 Solta
Medical, Inc. All rights reserved. Thermage, Fraxel, Fraxel
re:store and Solta Medical are trademarks or registered trademarks
of Solta Medical, Inc. or its subsidiaries. DATASOURCE: Solta
Medical, Inc. CONTACT: Michael Hromadik of Solta Medical, Inc.,
+1-510-780-4694, ; or Media, Chris Lalli of Cohn & Wolfe,
+1-415-365-8540, , for Solta Medical, Inc. Web Site:
http://www.solta.com/
Copyright